Stress eating and tuning out: Cancer cells re-wire metabolism to counter stress

References

• Akerboom TP, Bookelman H, Zuurendonk PF, et al. (1978). Intramitochondrial and extramitochondrial concentrations of adenine nucleotides and inorganic phosphate in isolated hepatocytes from fasted rats. Eur J Biochem 84:413–20
   PubMedGoogle Scholar
• Anastasiou D, Poulogiannis G, Asara JM, et al. (2011). Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334:1278–83
   PubMed Web of Science ®Google Scholar
• Anastasiou D, Yu Y, Israelsen WJ, et al. (2012). Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat Chem Biol 8:839–47
   PubMed Web of Science ®Google Scholar
• Ashizawa K, McPhie P, Lin KH, Cheng SY. (1991a). An in vitro novel mechanism of regulating the activity of pyruvate kinase M2 by thyroid hormone and fructose 1, 6-bisphosphate. Biochemistry 30:7105–11
   PubMed Web of Science ®Google Scholar
• Ashizawa K, Willingham MC, Liang CM, Cheng SY. (1991b). In vivo regulation of monomer-tetramer conversion of pyruvate kinase subtype M2 by glucose is mediated via fructose 1,6-bisphosphate. J Biol Chem 266:16842–6
   PubMed Web of Science ®Google Scholar
• Atsumi T, Chesney J, Metz C, et al. (2002). High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. Cancer Res 62:5881–7
   PubMed Web of Science ®Google Scholar
• Bar-Peled L, Schweitzer LD, Zoncu R, Sabatini DM. (2012). Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1. Cell 150:1196–208
   PubMed Web of Science ®Google Scholar
• Bensaad K, Tsuruta A, Selak MA, et al. (2006). TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126:107–20
   PubMed Web of Science ®Google Scholar
• Bluemlein K, Gruning NM, Feichtinger RG, et al. (2011). No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis. Oncotarget 2:393–400
   PubMed Web of Science ®Google Scholar
• Bruser A, Kirchberger J, Kloos M, et al. (2012). Functional linkage of adenine nucleotide binding sites in mammalian muscle 6-phosphofructokinase. J Biol Chem 287:17546–53
   PubMed Web of Science ®Google Scholar
• Cassago A, Ferreira AP, Ferreira IM, et al. (2012). Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism. Proc Natl Acad Sci U S A 109:1092–7
   PubMed Web of Science ®Google Scholar
• Chaneton B, Hillmann P, Zheng L, et al. (2012). Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature 491:458–62
   PubMed Web of Science ®Google Scholar
• Cheung EC, Athineos D, Lee P, et al. (2013). TIGAR Is Required for Efficient Intestinal Regeneration and Tumorigenesis. Dev Cell 25:463–77
   PubMed Web of Science ®Google Scholar
• Christofk HR, Vander Heiden MG, Wu N, et al. (2008). Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452:181–6
   PubMed Web of Science ®Google Scholar
• Clem BF, O’Neal J, Tapolsky G, et al. (2013). Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer. Mol Cancer Ther 12:1461--70
   Google Scholar
• Corcoran CA, Huang Y, Sheikh MS. (2006). The regulation of energy generating metabolic pathways by p53. Cancer Biol Ther 5:1610–3
   PubMed Web of Science ®Google Scholar
• Cortes-Cros M, Hemmerlin C, Ferretti S, et al. (2013). M2 isoform of pyruvate kinase is dispensable for tumor maintenance and growth. Proc Natl Acad Sci U S A 110:489–94
   PubMed Web of Science ®Google Scholar
• Costa Leite T, Da Silva D, Guimaraes Coelho R, et al. (2007). Lactate favours the dissociation of skeletal muscle 6-phosphofructo-1-kinase tetramers down-regulating the enzyme and muscle glycolysis. Biochem J 408:123–30
   PubMed Web of Science ®Google Scholar
• David CJ, Chen M, Assanah M, et al. (2010). HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 463:364–8
   PubMed Web of Science ®Google Scholar
• Delabarre B, Gross S, Fang C, et al. (2011). Full-length human glutaminase in complex with an allosteric inhibitor. Biochemistry 50:10764–70
   PubMed Web of Science ®Google Scholar
• Duran RV, Oppliger W, Robitaille AM, et al. (2012). Glutaminolysis activates Rag-mTORC1 signaling. Mol Cell 47:349–58
   PubMed Web of Science ®Google Scholar
• Erecinska M, Nelson D. (1990). Activation of glutamate dehydrogenase by leucine and its nonmetabolizable analogue in rat brain synaptosomes. J Neurochem 54:1335–43
   PubMed Web of Science ®Google Scholar
• Fahien LA, Kmiotek E. (1981). Regulation of glutamate dehydrogenase by palmitoyl-coenzyme A. Arch Biochem Biophys 212:247–53
   PubMed Web of Science ®Google Scholar
• Ferreras C, Hernandez ED, Martinez-Costa OH, Aragon JJ. (2009). Subunit interactions and composition of the fructose 6-phosphate catalytic site and the fructose 2,6-bisphosphate allosteric site of mammalian phosphofructokinase. J Biol Chem 284:9124–31
   PubMed Web of Science ®Google Scholar
• Friday E, Oliver R, Turturro F, Welbourne T. (2012). Role of glutamate dehydrogenase in cancer growth and homeostasis. In: Canuto RA, ed. Dehydrogenases. Rijeka, Croatia: InTech, 181--90
   Google Scholar
• Giacobbe A, Bongiorno-Borbone L, Bernassola F, et al. (2013). p63 regulates glutaminase 2 expression. Cell Cycle 12:1395–405
   PubMed Web of Science ®Google Scholar
• Goidts V, Bageritz J, Puccio L, et al. (2012). RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival. Oncogene 31:3235–43
   PubMed Web of Science ®Google Scholar
• Haigis MC, Mostoslavsky R, Haigis KM, et al. (2006). SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126:941–54
   PubMed Web of Science ®Google Scholar
• Han JM, Jeong SJ, Park MC, et al. (2012). Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 149:410–24
   PubMed Web of Science ®Google Scholar
• Hers HG, Van Schaftingen E. (1982). Fructose 2,6-bisphosphate 2 years after its discovery. Biochem J 206:1–12
   PubMed Web of Science ®Google Scholar
• Hitosugi T, Kang S, Vander Heiden MG, et al. (2009). Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal 2:ra73
   PubMed Web of Science ®Google Scholar
• Hitosugi T, Zhou L, Elf S, et al. (2012). Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. Cancer Cell 22:585–600
   PubMed Web of Science ®Google Scholar
• Hu W, Zhang C, Wu R, et al. (2010). Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci U S A 107:7455–60
   PubMed Web of Science ®Google Scholar
• Jenkins CM, Yang J, Sims HF, Gross RW. (2011). Reversible high affinity inhibition of phosphofructokinase-1 by acyl-CoA: a mechanism integrating glycolytic flux with lipid metabolism. J Biol Chem 286:11937–50
   PubMed Web of Science ®Google Scholar
• Jeong SM, Xiao C, Finley LW, et al. (2013). SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell 23:450–63
   PubMed Web of Science ®Google Scholar
• Kawaguchi A, Bloch K. (1976). Inhibition of glutamate dehydrogenase and malate dehydrogenases by palmitoyl coenzyme A. J Biol Chem 251:1406–12
   PubMed Web of Science ®Google Scholar
• Keller KE, Tan IS, Lee YS. (2012). SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions. Science 338:1069–72
   PubMed Web of Science ®Google Scholar
• Kemp RG, Gunasekera D. (2002). Evolution of the allosteric ligand sites of mammalian phosphofructo-1-kinase. Biochemistry 41:9426–30
   PubMed Web of Science ®Google Scholar
• Kessler R, Bleichert F, Warnke JP, Eschrich K. (2008). 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) is up-regulated in high-grade astrocytomas. J Neurooncol 86:257–64
   PubMed Web of Science ®Google Scholar
• Koppenol WH, Bounds PL, Dang CV. (2011). Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer 11:325–37
   PubMed Web of Science ®Google Scholar
• Kung C, Hixon J, Choe S, et al. (2012). Small molecule activation of PKM2 in cancer cells induces serine auxotrophy. Chem Biol 19:1187–98
   PubMed Web of Science ®Google Scholar
• Lai JC, Liang BB, Jarvi EJ, et al. (1993). Differential effects of fatty acyl coenzyme A derivatives on citrate synthase and glutamate dehydrogenase. Res Commun Chem Pathol Pharmacol 82:331–8
   PubMedGoogle Scholar
• Le A, Cooper CR, Gouw AM, et al. (2010). Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A 107:2037–42
   PubMed Web of Science ®Google Scholar
• Leite TC, Coelho RG, Da Silva D, et al. (2011). Lactate downregulates the glycolytic enzymes hexokinase and phosphofructokinase in diverse tissues from mice. FEBS Lett 585:92–8
   PubMed Web of Science ®Google Scholar
• Li C, Li M, Chen P, et al. (2011). Green tea polyphenols control dysregulated glutamate dehydrogenase in transgenic mice by hijacking the ADP activation site. J Biol Chem 286:34164–74
   PubMed Web of Science ®Google Scholar
• Li M., Li C, Allen A, et al. (2012). The structure and allosteric regulation of mammalian glutamate dehydrogenase. Arch Biochem Biophys 519:69–80
   PubMed Web of Science ®Google Scholar
• Liao S, Umekita Y, Guo J, et al. (1995). Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett 96:239–43
   PubMed Web of Science ®Google Scholar
• Locasale JW, Grassian AR, Melman T, et al. (2011). Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 43:869–74
   PubMed Web of Science ®Google Scholar
• Luo W, Hu H, Chang R, et al. (2011). Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145:732–44
   PubMed Web of Science ®Google Scholar
• Lv L, Li D, Zhao D, et al. (2011). Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. Mol Cell 42:719–30
   PubMed Web of Science ®Google Scholar
• Mattaini KR, Vander Heiden MG. (2012). Cancer. Glycosylation to adapt to stress. Science 337:925–6
   PubMed Web of Science ®Google Scholar
• Metallo CM, Gameiro PA, Bell EL, et al. (2012). Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481:380–4
   PubMed Web of Science ®Google Scholar
• Minchenko O, Opentanova I, Minchenko D, et al. (2004). Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1alpha activation. FEBS Lett 576:14–20
   PubMed Web of Science ®Google Scholar
• Mullen AR, Wheaton WW, Jin ES, et al. (2012). Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481:385–8
   PubMed Web of Science ®Google Scholar
• Nicklin P, Bergman P, Zhang B, et al. (2009). Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136:521–34
   PubMed Web of Science ®Google Scholar
• Noguchi T, Inoue H, Tanaka T. (1986). The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J Biol Chem 261:13807–12
   PubMed Web of Science ®Google Scholar
• Okar DA, Manzano A, Navarro-Sabate A, et al. (2001). PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem Sci 26:30–5
   PubMed Web of Science ®Google Scholar
• Pinheiro C, Longatto-Filho A, Azevedo-Silva J, et al. (2012). Role of monocarboxylate transporters in human cancers: state of the art. J Bioenerg Biomembr 44:127–39
   PubMed Web of Science ®Google Scholar
• Poorman RA, Randolph A, Kemp RG, Heinrikson RL. (1984). Evolution of phosphofructokinase – gene duplication and creation of new effector sites. Nature 309:467–9
   PubMed Web of Science ®Google Scholar
• Porter LD, Ibrahim H, Taylor L, Curthoys NP. (2002). Complexity and species variation of the kidney-type glutaminase gene. Physiol Genomics 9:157–66
   PubMed Web of Science ®Google Scholar
• Possemato R, Marks KM, Shaul YD, et al. (2011). Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476:346–50
   PubMed Web of Science ®Google Scholar
• Randle PJ, Garland PB, Hales CN, Newsholme EA. (1963). The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785–9
   PubMed Web of Science ®Google Scholar
• Reinhart GD. (1983). Influence of fructose 2,6-bisphosphate on the aggregation properties of rat liver phosphofructokinase. J Biol Chem 258:10827–30
   PubMedGoogle Scholar
• Ren F, Wu H, Lei Y, et al. (2010). Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma. Mol Cancer 9:81 doi:10.1186/1476-4598-9-81
   PubMed Web of Science ®Google Scholar
• Ros S, Santos CR, Moco S, et al. (2012). Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival. Cancer Discov 2:328–43
   PubMed Web of Science ®Google Scholar
• Ruiz-Lozano P, Hixon ML, Wagner MW, et al. (1999). p53 is a transcriptional activator of the muscle-specific phosphoglycerate mutase gene and contributes in vivo to the control of its cardiac expression. Cell Growth Differ 10:295–306
   PubMedGoogle Scholar
• Sakakibara R, Kato M, Okamura N, et al. (1997). Characterization of a human placental fructose-6-phosphate, 2-kinase/fructose-2,6-bisphosphatase. J Biochem 122:122–8
   PubMed Web of Science ®Google Scholar
• Shukla K, Ferraris DV, Thomas AG, et al. (2012). Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors. J Med Chem 55:10551–63
   PubMed Web of Science ®Google Scholar
• Son HJ, Ha SC, Hwang EY, et al. (2012). Roles of cysteine residues in the inhibition of human glutamate dehydrogenase by palmitoyl-CoA. BMB Rep 45:707–12
   PubMed Web of Science ®Google Scholar
• Sonveaux P, Vegran F, Schroeder T, et al. (2008). Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 118:3930–42
   PubMed Web of Science ®Google Scholar
• Stanley CA, Lieu YK, Hsu BY, et al. (1998). Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N Engl J Med 338:1352–7
   PubMed Web of Science ®Google Scholar
• Suzuki S, Tanaka T, Poyurovsky MV, et al. (2010). Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci U S A 107:7461–6
   PubMed Web of Science ®Google Scholar
• Taylor RP, Parker GJ, Hazel MW, et al. (2008). Glucose deprivation stimulates O-GlcNAc modification of proteins through up-regulation of O-linked N-acetylglucosaminyltransferase. J Biol Chem 283:6050–7
   PubMed Web of Science ®Google Scholar
• Thangavelu K, Pan CQ, Karlberg T, et al. (2012). Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism. Proc Natl Acad Sci U S A 109:7705–10
   PubMed Web of Science ®Google Scholar
• Tomita T, Kuzuyama T, Nishiyama M. (2011). Structural basis for leucine-induced allosteric activation of glutamate dehydrogenase. J Biol Chem 286:37406–13
   PubMed Web of Science ®Google Scholar
• Usenik A, Legisa M. (2010). Evolution of allosteric citrate binding sites on 6-phosphofructo-1-kinase. PLoS One 5:e15447
   Google Scholar
• Uyeda K. (1979). Phosphofructokinase. Adv Enzymol Relat Areas Mol Biol 48:193–244
   PubMedGoogle Scholar
• Vander Heiden MG, Locasale JW, Swanson KD, et al. (2010). Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 329:1492–9
   PubMed Web of Science ®Google Scholar
• Wamelink MM, Struys EA, Jakobs C. (2008). The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review. J Inherit Metab Dis 31:703–17
   PubMed Web of Science ®Google Scholar
• Wang JB, Erickson JW, Fuji R, et al. (2010). Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 18:207–19
   PubMed Web of Science ®Google Scholar
• Wanka C, Steinbach JP, Rieger J. (2012). Tp53-induced glycolysis and apoptosis regulator (TIGAR) protects glioma cells from starvation-induced cell death by up-regulating respiration and improving cellular redox homeostasis. J Biol Chem 287:33436–46
   PubMed Web of Science ®Google Scholar
• Ward PS, Thompson CB. (2012). Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 21:297–308
   PubMed Web of Science ®Google Scholar
• Wise DR, Thompson CB. (2010). Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci 35:427–33
   PubMed Web of Science ®Google Scholar
• Wise DR, Ward PS, Shay JE, et al. (2011). Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci U S A 108:19611–16
   PubMed Web of Science ®Google Scholar
• Wong N, De Melo J, Tang D. (2013). PKM2, a central point of regulation in cancer metabolism. Int J Cell Biol 2013:242513
   PubMedGoogle Scholar
• Xiang L, Xie G, Liu C, et al. (2013). Knock-down of glutaminase 2 expression decreases glutathione, NADH, and sensitizes cervical cancer to ionizing radiation. Biochim Biophys Acta 1833:2996--3005
   Google Scholar
• Yang W, Xia Y, Hawke D, et al. (2012). PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell 150:685–96
   PubMed Web of Science ®Google Scholar
• Yang W, Xia Y, Ji H, et al. (2011). Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation. Nature 480:118–22
   PubMed Web of Science ®Google Scholar
• Ye J, Mancuso A, Tong X, et al. (2012). Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc Natl Acad Sci U S A 109:6904–9
   PubMed Web of Science ®Google Scholar
• Yi W, Clark PM, Mason DE, et al. (2012). Phosphofructokinase 1 glycosylation regulates cell growth and metabolism. Science 337:975–80
   PubMed Web of Science ®Google Scholar
• Yoo H, Antoniewicz MR, Stephanopoulos G, Kelleher JK. (2008). Quantifying reductive carboxylation flux of glutamine to lipid in a brown adipocyte cell line. J Biol Chem 283:20621–7
   PubMed Web of Science ®Google Scholar
• Yun SJ, Jo SW, Ha YS, et al. (2012). PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer. Urol Oncol 30:893–9
   PubMed Web of Science ®Google Scholar
• Zachara NE, O’Donnell N, Cheung WD, et al. (2004). Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J Biol Chem 279:30133–42
   PubMed Web of Science ®Google Scholar
• Zoncu R, Bar-Peled L, Efeyan A, et al. (2011). mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science 334:678–83
   PubMed Web of Science ®Google Scholar